Alexander Hardy Feisty, stubborn Jean-Jacques Bienaimé is stepping down from the top post at BioMarin after an 18-year run with a string of highlights in 2023. And he’s handing the reins to his carefully-picked successor: Alexander Hardy, the CEO at industry stalwart Genentech.
The change…
Click here to view original post
